10.07.2017 23:07:00
|
Onychomycosis Market (Prescription Drugs) US Industry Trends, Share, Size, Growth, Opportunity and Forecasts Report Now Available at MarketReportsOnline.com
PUNE, India, July 10, 2017 /PRNewswire-iReach/ -- The report entitled "The US Onychomycosis Market (2017 Edition)", provides analysis of the US onychomycosis market, with detailed analysis of market size and growth, market share and economic impact of the industry. The analysis includes the market by value, by volume and by segments. The report also includes the detailed analysis of the segments of the onychomycosis market, comprising of market by value, by volume and by average prices.
Complete report on Onychomycosis market spread across 49 pages with providing 4 company profiles, 2 tables and 21 figures is now available at http://www.marketreportsonline.com/616679.html.
Valeant Pharmaceuticals, Pfizer, Inc., Novartis AG and Johnson & Johnson are some of the key players operating in the US onychomycosis market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage: Valeant Pahrmaceuticals, Pfizer, Inc., Johnson and Johnson, Novartis AG
Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated. Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.
Purchase a copy of this "The US Onychomycosis Market (2017 Edition)" research report at USD 750 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=616679.
There are five types of Onychomycosis: Distal Subungual Onychomycosis, White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx onychomycosis and Candidal onychomycosis. Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc.
The US onychomycosis market (prescription drugs) has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period. The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.
Major Points from Table of Contents
1. Executive Summary
2. Introduction
2.1 Onychomycosis: An Overview
2.2 Types of Onychomycosis
2.3 Treatment for Onychomycosis
3. The US Market Analysis
3.1 The US Onychomycosis Market by Prevalence
3.2 The US Nail Care Market: An Analysis
3.3 The US Kerydin Drug Market: An Anlalysis
3.4 The US Jublia Drug Market: An Analysis
3.5 The US Generic Drugs Market: An Analysis
3.6 Onychomycosis Market: New Drugs Overview
4. Competitive Landscape
4.1 Competition in Onychomycosis Prescription Market: An Overview
4.2 Financial Comparison of Major Players of the US Onychomycosis Market
5. Company Profiling
Explore more latest reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Media Contact:Ritesh Tiwari, MarketReportsOnline, + 1 888 391 5441, sales@marketreportsonline.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Market Reports Online
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!